Innova Medical Design

Innova Medical Design

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Innova Medical Design is a U.S.-based medical device developer specializing in needle pain relief technologies. Operating since 2008, the company is positioned in the large and growing market for patient-centric drug delivery and procedural comfort solutions. As a private entity, it likely relies on investor funding and partnership deals to advance its product development efforts. The company's focus on a common, yet often unaddressed, procedural pain point presents a clear market opportunity, though it faces competition and the challenges of commercializing a medical device.

Procedural Pain

Technology Platform

Focused on medical device innovations for reducing pain associated with needle insertion, potentially involving needle design, integrated sensory disruption, or procedural modifications.

Opportunities

The global need for improved patient experience in needle-based procedures is vast, spanning pediatrics, chronic disease management, and vaccination programs.
A successful device could partner with pharmaceutical companies to enhance drug delivery systems or be adopted directly by healthcare providers seeking to improve patient compliance and satisfaction.

Risk Factors

The company faces high regulatory hurdles for medical device clearance, significant competition from both direct device competitors and indirect pain management methods, and commercial challenges in convincing cost-conscious healthcare systems to adopt a new procedural tool.
The lack of recent public information raises fundamental risks about its ongoing operational and financial viability.

Competitive Landscape

Competition includes companies developing needle-free injection technologies (e.g., jet injectors), topical anesthetic products, and other pain-distraction devices. Larger medical device firms in the drug delivery space (e.g., Becton Dickinson, Gerresheimer) also represent competitive threats, as they have the resources to develop or acquire similar technologies and integrate them into their broad product portfolios.